Ellington Management Group’s Celgene Corp CELG Stock Holding History

Ellington Management Group’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-7,200	Closed	-$642K	–	1041
2018 Q1	$642K	Sell	7,200 -6,500	-47%	-$624K	0.05%	344
2017 Q4	$1.43M	Buy	13,700 +7,900	+136%	+$891K	0.23%	51
2017 Q3	$846K	Buy	+5,800	New	+$790K	0.14%	92
2017 Q1	–	Sell	-5,200	Closed	-$602K	–	989
2016 Q4	$602K	Sell	5,200 -2,000	-28%	-$223K	0.09%	179
2016 Q3	$753K	Buy	+7,200	New	+$779K	0.21%	141
2015 Q4	–	Sell	-2,100	Closed	-$227K	–	997
2015 Q3	$227K	Buy	+2,100	New	+$261K	0.06%	524
2013 Q4	–	Sell	-8,600	Closed	-$663K	–	1006
2013 Q3	$663K	Buy	+8,600	New	+$603K	0.13%	207

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ellington Management Group's CELG Position: Q2 2018 in Review

Ellington Management Group sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 7,200 shares — an estimated $642K sold.

Ellington Management Group first reported a position in CELG in Q3 2013 and held it in 7 quarters. The position peaked at $1.43M in Q4 2017. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

Ellington Management Group reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
Ellington Management Group sold 7,200 Celgene Corp shares in Q2 2018, an estimated $642K.
Ellington Management Group first reported a position in Celgene Corp in Q3 2013 and held it in 7 quarters.
Ellington Management Group's Celgene Corp position peaked at $1.43M in Q4 2017.
1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Ellington Management Group's 13F filing for Q2 2018, filed 14 Aug 2018.